• Climb Bio to Present at Upcoming Investor Conferences

    来源: Nasdaq GlobeNewswire / 31 10月 2024 07:00:00   America/New_York

    WELLESLEY, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced that members of its executive team are scheduled to participate in the upcoming investor conferences detailed below.

    Guggenheim Securities Healthcare Innovation Conference
    Format: Fireside chat and one-on-one investor meetings
    Date: November 11-12, 2024

    Stifel 2024 Healthcare Conference
    Format: Fireside chat and one-on-one investor meetings
    Date: November 18-19, 2024

    36th Annual Piper Sandler Healthcare Conference
    Format: Fireside chat and one-on-one investor meetings
    Date: December 3-5, 2024

    7th Annual Evercore ISI HealthCONx Conference
    Format: Fireside chat and one-on-one investor meetings
    Date: December 3-5, 2024

    The presentations will be webcast live and available for replay under “News & Events” in the Investors section of the Company's website at climbbio.com.

    About Climb Bio, Inc.
    Climb Bio, Inc., is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company’s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases. For more information, please visit climbbio.com.

    Investors
    Chris Brinzey
    ICR Healthcare
    chris.brinzey@ICRhealthcare.com
    339-970-2843

    Media
    Jon Yu
    ICR Healthcare
    jon.yu@icrhealthcare.com
    475-395-5375


    Primary Logo

分享